OZiva has introduced its new Acne Spot Corrector, a plant-based skincare product designed for active acne. According to the brand, the product is formulated with plant-powered ingredients and is intended to reduce acne without drying the skin or affecting the skin barrier.
Ahead of the launch, OZiva partnered with acne advocate Prableen Kaur Bhomrah to test the product before making it commercially available. The initiative also involved 100 members of her community, who were invited to use the product and share their feedback before its release.
The campaign, built around the message ‘If She Says No, We Don’t Launch,’ focuses on consumer testing before product rollout rather than traditional promotional campaigns. It reflects a broader trend in the skincare industry, where brands are increasingly using community feedback and product validation as part of the launch process.
The launch also comes as consumers continue to seek acne care products backed by clinical testing and transparent ingredient claims. Many acne treatments rely on acid-based formulations that may cause dryness or irritation, prompting demand for alternative approaches designed to balance efficacy with skin barrier support.
According to OZiva, the Acne Spot Corrector was clinically evaluated on Indian acne-prone skin and recorded a 25.72% reduction in overall acne severity over seven days. The brand said all study participants showed visible improvement during the evaluation period.
View this post on Instagram
View this post on Instagram
Sharing her experience, Prableen Kaur Bhomrah, said, “For anyone who has dealt with acne, skincare is never just about products; it is about trust. What stood out to me about this campaign was the freedom to share my honest experience without filters or scripted messaging. My community has always valued authenticity, especially when it comes to conversations around acne and skin confidence.”
She further added, “It was refreshing to see a brand willing to place consumer trust above traditional marketing. That openness is what made this collaboration meaningful, and I believe it reflects what today’s beauty consumers are looking for.”
Ratna Upadhyay, Sr. Manager R&D at OZiva, said “With OZiva Spot Corrector, our goal was to develop a next-generation acne correction formula that addresses the multiple biological drivers of acne, including excess sebum production, inflammation, follicular congestion, microbiome imbalance, and post-acne pigmentation.”
He further added, “Clinically benchmarked against conventional salicylic acid-led acne care, the OZiva Acne Care + Spot Corrector contains plant actives which has demonstrated 60% acne reduction in four weeks versus approximately 23.8% with conventional salicylic acid benchmarks, along with up to 58% reduction in sebum overproduction and 15% improvement in skin hydration, reinforcing that acne correction does not have to come at the cost of skin comfort.”
